
WASHINGTON, Sept. 17 (UPI) -- Two U.S. Department of Health and Human Services agencies announced Monday they will collaborate in a review of ADHD drugs.
Officials at the Food and Drug Administration and the Agency for Healthcare Research and Quality said they will conduct the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder to determine the drugs' potential for increased risk of heart attack, stroke or other cardiovascular problems.
The review will include the clinical data of about 500,000 children and adults who have taken medications used to treat ADHD.
The two-year study will be coordinated by Vanderbilt University. Data analysis will be performed by researchers at Vanderbilt, Kaiser Permanente of California, the HMO Research Network and i3 Drug Safety, an Ingenix company.
|
|
|
|
|
|
| Additional Science News Stories | |
TEHRAN, Feb. 13 (UPI) --
The bomb attacks on Israeli embassy staff in India and Georgia were the work of Israel itself, an Iranian Foreign Ministry spokesman said.
|
NEW YORK, Feb. 13 (UPI) --
Kate Upton was revealed as the cover model of the 2012 Sports Illustrated Swimsuit Issue during Monday's taping of "Late Show" in New York.
|
PITTSBURGH, Feb. 13 (UPI) --
Researchers say offshore wind farms planned for the Atlantic and the Gulf of Mexico face severe risks from hurricanes that could destroy half of them.
|
Women, Liberal Democrats favor Valentine's … $55,000 cupcake comes with diamond ring … 400-year-old witchcraft trial reopened … Survey: Many Swedes believe in ghosts … Watercooler stories from UPI.
|
| Stories | Photos | People | Comments |
View Caption